Chai Discovery Headlines

PharmaDeviceNews

Analysis of Chai Discovery's collaboration with Lilly TuneLab, exploring its strategic implications for AI-designed biologics.

Companies:Chai Discovery

FinancialContent

Chai Discovery announces collaboration with Lilly TuneLab to make its miniprotein design suite available on free trial to select biotechs, with deployment license for further work.

Companies:Chai Discovery

AllSci News

Chai Discovery's AI miniprotein design suite is made available on Lilly TuneLab for select biotech partners.

Companies:Chai Discovery

BusinessWire

Chai Discovery announces a collaboration with Lilly TuneLab to make its AI miniprotein design suite available for free trial to select biotechs.

Companies:Chai Discovery

IntuitionLabs

A detailed analysis of Chai Discovery's technology and the Pfizer deal, discussing generative antibody design and pharma AI strategy.

Companies:Chai Discovery

Pharmacy Times

An analysis of the Chai Discovery-Eli Lilly collaboration, highlighting the role of AI in biologics discovery and the potential impact.

Companies:Chai Discovery

AI Weekly

Pfizer licenses Chai-3 AI model from Chai Discovery to design antibodies for undruggable targets, with custom model trained on Pfizer's data.

Companies:Chai Discovery

HealthCare Middle East & Africa

Pfizer enters licensing agreement with Chai Discovery to accelerate drug discovery using AI, gaining early access to Chai-3.

Companies:Chai Discovery

OpenDataScience

Pfizer licenses Chai Discovery's AI platform to accelerate antibody design using Chai-3.

Companies:Chai Discovery

Pharmaceutical Technology

Pfizer signs a licensing agreement with Chai Discovery to integrate its AI platform into drug discovery operations, gaining access to Chai-3 model.

Companies:Chai Discovery

Pharmaceutical Tech

Chai Discovery enters a licensing agreement with Pfizer to integrate its AI platform into Pfizer's drug discovery operations.

Companies:Chai Discovery

American Pharmaceutical Review

Pfizer licenses Chai Discovery's AI platform for drug research, including access to Chai-3 and a custom model.

Companies:Chai Discovery

BioSpace

Chai Discovery announces a licensing agreement with Pfizer, giving Pfizer early access to Chai-3 and a custom model.

Companies:Chai Discovery

Pharma Journalist

Chai Discovery enters a licensing agreement with Pfizer, giving Pfizer access to its AI platform and Chai-3 model.

Companies:Chai Discovery

Yahoo Finance

Pfizer has licensed Chai Discovery's AI drug discovery platform, gaining access to the Chai-3 model and a custom model trained on Pfizer's data.

Companies:Chai Discovery

NEWSx.io

A detailed feature on Chai Discovery, covering its partnerships with Pfizer and Eli Lilly, its technology, and its $1.3 billion valuation.

Companies:Chai Discovery

Contract Pharma

Pfizer leverages Chai Discovery's AI platform including Chai-3 to accelerate drug discovery research.

Companies:Chai Discovery

Business Wire

Chai Discovery announces a license agreement with Pfizer, granting Pfizer access to its AI platform including the Chai-3 model to accelerate drug discovery.

Companies:Chai Discovery

Yahoo Finance

Chai Discovery announces a licensing agreement with Pfizer, providing early access to Chai-3 and a custom model.

Companies:Chai Discovery

MarketMinute

Chai Discovery announces a license agreement with Pfizer to use its AI platform, including the Chai-3 model, to accelerate drug discovery.

Companies:Chai Discovery

Forbes

Chai Discovery is working with major drugmakers to use its latest antibody AI model to find new therapies. Now it’s in talks to raise $400 million more VC funding at a $3.4 billion valuation, Forbes has learned.

Companies:Chai Discovery

TechFastForward

The article reports on record AI drug discovery funding in Q1 2026, including Chai Discovery's $130M Series B with OpenAI participation.

Companies:Chai Discovery

theaiinsider.tech

The article lists 20 enterprise AI drug discovery CEOs, including Chai Discovery's Josh Meier, and highlights the company's $130M Series B, $1.3B valuation, and focus on AI-driven molecular design.

Companies:Chai Discovery

IntuitionLabs

In-depth analysis of Chai Discovery's partnership with Eli Lilly for AI biologics design.

Companies:Chai Discovery

GEN (Genetic Engineering & Biotechnology News)

Eli Lilly announced collaborations with several partners, including Chai Discovery, to expand its AI footprint in drug discovery.

Companies:Chai Discovery